Skip to main content
Caplight Logo









Prevision Medicine AG

Prevision Medicine AG

Private
SchlierenHealthcare & Life Scienceshttps://previsionmedicine.com/

Last Round

Grant

Mar 6, 2026

Total Funding Raised

$220,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Prevision Medicine AG is a biotechnology company that provides a functional precision oncology platform to guide personalized cancer treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision medicineex vivo drug screeningfunctional precision medicinedrug sensitivity testingtechbiopersonalized oncologycancer diagnosticsdeep morphology learningclinical decision supportsingle-cell analysispatient-derived modelsresearch-use-onlyRUOorganoid screeningai-driven drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prevision Medicine AG Comparables

Compare Prevision Medicine AG with similar companies based on industry and business-model similarity.

Prevision Medicine AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KYAN Technologies
84%
First Ascent Biomedical
83%
Travera
82%

Prevision Medicine AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 6, 2026
GrantNov 6, 2025
Pre SeedSep 8, 2025
AngelSep 1, 2025

Key People

Founding team and executive leadership

Philip Zimmermann

CEO and Co-Founder

Founding Team

Prevision Medicine AG Investors

Notable investors and investment history

Prevision Medicine AG investors
InvestorRounds
EPFL Innovation ParkGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2026

    Grew 44% QoQ from 9 to 13 employees.

  • Sep 8, 2025

    Completed a Pre Seed funding round.

Prevision Medicine AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prevision Medicine AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prevision Medicine AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren
Employee Range13
Year Founded2024
Last FundingMar 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?